These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
216 related items for PubMed ID: 6510472
1. Characteristics of the binding of platelet-activating factor to platelets of different animal species. Iñarrea P, Gomez-Cambronero J, Nieto M, Crespo MS. Eur J Pharmacol; 1984 Oct 15; 105(3-4):309-15. PubMed ID: 6510472 [Abstract] [Full Text] [Related]
2. Specific binding of [3H]-1-O-octadecyl Paf-acether to washed human platelets. Tuffin DP, Davey P, Dyer RL, Lunt DO, Wade PJ. Adv Exp Med Biol; 1985 Oct 15; 192():83-96. PubMed ID: 3834789 [Abstract] [Full Text] [Related]
3. Effect of calcium and calcium antagonists on [3H]-Paf-acether binding to washed human platelets. Wade PJ, Lunt DO, Lad N, Tuffin DP, McCullagh KG. Thromb Res; 1986 Jan 15; 41(2):251-62. PubMed ID: 3961730 [Abstract] [Full Text] [Related]
4. Binding kinetics of PAF-acether (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) to intact human platelets. Kloprogge E, Akkerman JW. Biochem J; 1984 Nov 01; 223(3):901-9. PubMed ID: 6150705 [Abstract] [Full Text] [Related]
5. Inhibition by CV-3988 of the binding of [3H]-platelet activating factor (PAF) to the platelet. Terashita Z, Imura Y, Nishikawa K. Biochem Pharmacol; 1985 May 01; 34(9):1491-5. PubMed ID: 2986648 [Abstract] [Full Text] [Related]
6. Conversion of 3H-PAF acether by rabbit platelets is independent from aggregation: evidences for a novel metabolite. Touqui L, Jacquemin C, Vargaftig BB. Biochem Biophys Res Commun; 1983 Feb 10; 110(3):890-3. PubMed ID: 6838557 [Abstract] [Full Text] [Related]
7. BN 52021 displaces [3H]paf-acether from, and inhibits its binding to intact human platelets. Korth R, Benveniste J. Eur J Pharmacol; 1987 Oct 27; 142(3):331-41. PubMed ID: 3428349 [Abstract] [Full Text] [Related]
8. 1-O-alkyl-2-acyl-sn-glycero-3-phosphorylcholine is the precursor of platelet-activating factor in stimulated rabbit platelets. Evidence for an alkylacetyl-glycerophosphorylcholine cycle. Touqui L, Jacquemin C, Dumarey C, Vargaftig BB. Biochim Biophys Acta; 1985 Jan 09; 833(1):111-8. PubMed ID: 3967037 [Abstract] [Full Text] [Related]
9. The role of Ca2+ in regulating the catabolism of PAF-acether (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) in rabbit platelets. Touqui L, Shaw AM, Dumarey C, Jacquemin C, Vargaftig BB. Biochem J; 1987 Jan 15; 241(2):555-60. PubMed ID: 3109377 [Abstract] [Full Text] [Related]
10. Release of platelet-activating factor (PAF-acether) and 2-lyso PAF-acether from three cell types. Benveniste J, Roubin R, Chignard M, Jouvin-Marche E, Le Couedic JP. Agents Actions; 1982 Dec 15; 12(5-6):711-3. PubMed ID: 7164945 [Abstract] [Full Text] [Related]
11. Paf-acether formation and arachidonic acid freeing from platelet ether-linked glyceryl-phosphorylcholine. Chignard M, Le Couedic JP, Coëffier E, Benveniste J. Biochem Biophys Res Commun; 1984 Oct 30; 124(2):637-43. PubMed ID: 6437404 [Abstract] [Full Text] [Related]
12. Desaggregation of PAF-acether-aggregated platelets by verapamil and TMB-8 with reversal of phosphorylation of 40K and 20K proteins. Khan SN, Lane PA, Smith AD. Eur J Pharmacol; 1985 Jan 02; 107(2):189-98. PubMed ID: 3920056 [Abstract] [Full Text] [Related]
13. Degranulation of rabbit platelets with PAF-acether: a new procedure for unravelling the mode of action of platelet-activating substances. Vargaftig BB, Joseph D, Marlas G, Chevance LG. Thromb Haemost; 1982 Aug 24; 48(1):67-71. PubMed ID: 7135345 [Abstract] [Full Text] [Related]
14. Kinetics of platelet-activating factor 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine-induced fibrinogen binding to human platelets. Kloprogge E, Mommersteeg M, Akkerman JW. J Biol Chem; 1986 Aug 25; 261(24):11071-6. PubMed ID: 3015954 [Abstract] [Full Text] [Related]
15. PAF binding sites. Characterization by [3H]52770 RP, a pyrrolo[1,2-c]thiazole derivative, in rabbit platelets. Robaut C, Durand G, James C, Lave D, Sedivy P, Floch A, Mondot S, Pacot D, Cavero I, Le Fur G. Biochem Pharmacol; 1987 Oct 01; 36(19):3221-9. PubMed ID: 2822048 [Abstract] [Full Text] [Related]
16. Changes in cytosolic free calcium induced by platelet-activating factor in rabbit platelets: specific inhibition by BN 52021 and structurally related compounds. Baroggi N, Etienne A, Braquet P. Agents Actions Suppl; 1986 Oct 01; 20():87-97. PubMed ID: 3028108 [Abstract] [Full Text] [Related]
17. Unsaturated platelet-activating factor: influence on aggregation, serotonin release and thromboxane synthesis of human thrombocytes. Korth R, Riess H, Brehm G, Hiller E. Thromb Res; 1986 Mar 01; 41(5):699-706. PubMed ID: 3961742 [Abstract] [Full Text] [Related]
18. Platelet-activating factor-induced calcium mobilization in human platelets and neutrophils: effects of PAF-acether antagonists. Selak MA, Smith JB. J Lipid Mediat; 1989 Mar 01; 1(2):125-37. PubMed ID: 2519888 [Abstract] [Full Text] [Related]
19. Lack of correlation between cytotoxicity of agonists and antagonists of platelet activating factor [paf-acether] in neoplastic cells and modulation of [3H]-paf-acether binding to platelets from humans in vitro. Berdel WE, Korth R, Reichert A, Houlihan WJ, Bicker U, Nomura H, Vogler WR, Benveniste J, Rastetter J. Anticancer Res; 1987 Mar 01; 7(6):1181-7. PubMed ID: 3442414 [Abstract] [Full Text] [Related]
20. Properties of PAF-acether-induced platelet aggregation and secretion. Studies in gel-filtered human platelets. Kloprogge E, de Haas GH, Gorter G, Akkerman JW. Thromb Res; 1983 Mar 15; 29(6):595-608. PubMed ID: 6222507 [Abstract] [Full Text] [Related] Page: [Next] [New Search]